{
  "trial_id": "NCT04737655",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Maintenance therapy (LAMA or LABA) for COPD",
      "label": "met",
      "evidence": "The patient is a known case of COPD since 2 years ago."
    },
    {
      "criterion": "Age >18",
      "label": "met",
      "evidence": "The patient is a 60-year-old Spanish man."
    },
    {
      "criterion": "Admission for AE of COPD",
      "label": "met",
      "evidence": "The patient was admitted in the ICU for an acute exacerbation of COPD."
    },
    {
      "criterion": "Signed Inform consent",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Admitted in ICU >24h",
      "label": "met",
      "evidence": "The patient is acutely ill but oriented and conscious, and has been admitted to the ICU for at least 24 hours."
    },
    {
      "criterion": "In the ICU, the standard of care is still focused on the use of aerosolized therapies.",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "The use of new ventilation techniques like high flow canula oxygen therapy is also challenging in the particular context of inhaled therapies.",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "As the use of triple therapy is now the standard of care in COPD patients experiencing a severe exacerbation, it is the objective to propose the introduction of Trimbow as soon as possible following the onset of a severe exacerbation, even in critically ill patients.",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "3 Study objectives",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Evaluate the non inferiority of Trimbow associated with the standard of care in comparison with the standard of care alone.",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Evaluate the other ICU-stay outcomes and long term outcomes of the patients.",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "An open label, prospective randomized trial",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "No CI for studied medication",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Not treated with studied medication for at least 3 months",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Admitted in ICU for AE of COPD within the past 3 months",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Intolerance to studied medication",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Hospitalized since >6 days",
      "label": "not_met",
      "evidence": "The patient has been admitted to the ICU for at least 24 hours."
    },
    {
      "criterion": "ARDS condition (PAFI <200)",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Admitted in ICU >72H",
      "label": "not_met",
      "evidence": "The patient has been admitted to the ICU for at least 24 hours."
    },
    {
      "criterion": "Patient with severe asthma",
      "label": "not_met",
      "evidence": ""
    }
  ],
  "notes": "The patient is a known case of COPD since 2 years ago, and was admitted in the ICU for an acute exacerbation of COPD. The patient has been treated with aerosolized therapies, but the standard of care is still focused on these treatments.",
  "_meta": {
    "topic_id": "28",
    "trial_id": "NCT04737655",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}